Home » Newsletters » BioWorld Science

BioWorld Science

July 7, 2014

View Archived Issues

Novel GLP-1 agonist TTP-273 reduces glucose levels in type 2 diabetes patients

Manganese porphyrin antioxidant ameliorates experimental type 2 diabetes

Kyowa Hakko Kirin to start new phase II study of bardoxolone methyl

Amarantus announces toxicology data for MANF in retinitis pigmentosa

Jazz Pharmaceuticals gains rights to Defitelio in the Americas from Sigma-Tau

Synchroneuron's development of SNC-102 supported by Series B funding

Novel beta2-adrenoceptor agonists for the treatment of respiratory disorders

Voltage-gated calcium channels, potential targets for chronic pain

AVEO Pharmaceuticals discloses novel anti-FGFR-2 MAbs

AIMM Therapeutics to receive milestone payment

First patients dosed in a phase II trial of the novel antibiotic SMT-19969

Dual calcitonin and amylin receptor agonists show potential for obesity, diabetes and osteoarthritis

Dermira licenses Cimzia for psoriasis

Novel nonsense mutation suppressors patented by Novartis

Cellceutix designs novel agents for bacterial infections and cancer

Sumitomo Dainippon Pharma discloses new 5-HT4 receptor agonists

Roche discloses novel BTK inhibitors

Aegis Therapeutics seeks to out-license octreotide nasal spray

Glenmark's GBR-830 enters human trials for autoimmune diseases

Teva Pharmaceutical receives positive CHMP opinion for Seasonique

Japanese approval of Alecensa for ALK-positive NSCLC

Nivolumab, the first drug targeting PD-1 approved

Japanese approval for biosimilar infliximab

European approval for Arzerra in first-line treatment of CLL

Kitasato Daiichi Sankyo Vaccine obtains pertussis-diphtheria-tetanus-polio vaccine licenses

Deltyba approved in Japan for multidrug-resistant tuberculosis

Canagliflozin approved in Japan for type 2 diabetes

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 10, 2025.
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
Astellas’ ASP-2246 shows promise in stroke management
BioWorld Science
Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...
News in brief
BioWorld Asia
BioWorld Asia briefs for Feb. 10, 2026